Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
31-45 of 350
Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Project Oncology®Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
AudioAbstractsAlectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
Ryan Quigley
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Brian P. McDonough, MD, FAAFP
Richard Kim, MD
How Delayed Colorectal Cancer Screening Impacts Quality of Life
Clinician's RoundtableHow Delayed Colorectal Cancer Screening Impacts Quality of Life
Christopher Cann, MD
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's RoundtableThe Clinical Consequences of Delayed Colorectal Cancer Screening
Peter Buch, MD, FACG, AGAF, FACP
Christopher Cann, MD
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
- advertisement
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®The Epigenetics of Lung Cancer Dormancy and Relapse
Advancing Care for Men with Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Care for Men with Breast Cancer
Jose Pablo Leone, MD
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CENavigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Mariana C. Castells, MD, PhD
Tsewang Tashi, MD
Personalized Risk Communication and Its Effect on CRC Screening Choice
Clinician's RoundtablePersonalized Risk Communication and Its Effect on CRC Screening Choice
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's RoundtableRisk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerProtecting Heart Health in Metastatic Breast Cancer
Ryan Quigley
Gregory Vidal, MD, PhD
- advertisement
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Clinician's RoundtableEmbedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerThe Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley
Gregory Vidal, MD, PhD
Improving CRC Screening Uptake: An Integrated Approach
Clinician's RoundtableImproving CRC Screening Uptake: An Integrated Approach
Mallik Greene, PhD
